• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大剂量口服氟康唑治疗巴西利什曼原虫引起的皮肤利什曼病有效。

High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis.

机构信息

Department of Internal Medicine, School of Medicine, Federal University of Ceará,Fortaleza, Ceará, Brazil.

出版信息

Clin Infect Dis. 2011 Oct;53(7):693-5. doi: 10.1093/cid/cir496.

DOI:10.1093/cid/cir496
PMID:21890773
Abstract

We report for the first time the successful use of fluconazole to treat cutaneous leishmaniasis due to Leishmania braziliensis. We used escalating doses from 5 to 8 mg/kg per day. At a dose of 5 mg/kg per day, 75% patients were cured, and at 8 mg/kg per day, the cure rate was 100%. Fluconazole was well tolerated.

摘要

我们首次报告了氟康唑成功治疗巴西利什曼原虫引起的皮肤利什曼病。我们使用了 5 至 8 毫克/公斤/天的递增剂量。每天 5 毫克/公斤的剂量,75%的患者治愈,每天 8 毫克/公斤的剂量,治愈率为 100%。氟康唑耐受性良好。

相似文献

1
High-dose oral fluconazole therapy effective for cutaneous leishmaniasis due to Leishmania (Vianna) braziliensis.大剂量口服氟康唑治疗巴西利什曼原虫引起的皮肤利什曼病有效。
Clin Infect Dis. 2011 Oct;53(7):693-5. doi: 10.1093/cid/cir496.
2
Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial.氟康唑治疗巴西利什曼原虫引起的皮肤利什曼病:一项随机对照试验。
Clin Infect Dis. 2017 Jan 1;64(1):67-71. doi: 10.1093/cid/ciw662. Epub 2016 Nov 1.
3
Fluconazole effectiveness against Leishmania (Viannia) braziliensis: is the evidence enough?氟康唑对巴西利什曼原虫(维安尼亚亚属)的有效性:证据充分吗?
Clin Infect Dis. 2012 Jul;55(2):309; author reply 309-10. doi: 10.1093/cid/cis396. Epub 2012 Apr 20.
4
Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.米替福新治疗玻利维亚皮肤利什曼病的疗效。
Am J Trop Med Hyg. 2008 Feb;78(2):210-1.
5
Successful treatment of childhood cutaneous leishmaniasis with liposomal amphotericin B: report of two cases.儿童皮肤利什曼病经两性霉素 B 脂质体成功治疗:两例报告。
J Trop Pediatr. 2010 Apr;56(2):122-4. doi: 10.1093/tropej/fmp073. Epub 2009 Aug 5.
6
Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.局部注射锑剂治疗玻利维亚皮肤利什曼病单发性皮损。
Clin Infect Dis. 2013 May;56(9):1255-60. doi: 10.1093/cid/cit049. Epub 2013 Feb 6.
7
Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.脂质体两性霉素B与葡糖酸锑钠治疗巴西利什曼原虫引起的皮肤感染的比较。
J Am Acad Dermatol. 2007 Apr;56(4):612-6. doi: 10.1016/j.jaad.2006.06.044. Epub 2007 Feb 5.
8
Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis.脂质体两性霉素B成功治疗巴西利什曼原虫皮肤利什曼病。
Br J Dermatol. 2005 Jul;153(1):203-5. doi: 10.1111/j.1365-2133.2005.06670.x.
9
A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.一项比较口服阿奇霉素和葡甲胺锑酸盐治疗由巴西利什曼原虫(维安尼亚利什曼原虫)引起的美洲皮肤利什曼病的随机临床试验。
Am J Trop Med Hyg. 2007 Oct;77(4):640-6.
10
Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.米替福新治疗巴西利什曼原虫引起的皮肤利什曼病:一项随机对照试验。
PLoS Negl Trop Dis. 2010 Dec 21;4(12):e912. doi: 10.1371/journal.pntd.0000912.

引用本文的文献

1
Comparing the efficacy of fluconazole and cryotherapy Versus cryotherapy alone on treating cutaneous leishmaniasis: a triple-blind randomized clinical trial.比较氟康唑和冷冻疗法与单纯冷冻疗法治疗皮肤利什曼病的疗效:一项三盲随机临床试验。
BMC Infect Dis. 2024 Mar 20;24(1):332. doi: 10.1186/s12879-024-09211-5.
2
Antiparasitic effect of Farnesol against Leishmania major: A rationale from in vitro and in silico investigations.法尼醇抗利什曼原虫的驱虫作用:体外和计算机模拟研究的原理。
PLoS One. 2023 Nov 6;18(11):e0293290. doi: 10.1371/journal.pone.0293290. eCollection 2023.
3
Evaluation of farnesol orally and topically against experimental cutaneous leishmaniasis: In -vivo analysis.
评估法尼醇口服和局部治疗实验性皮肤利什曼病:体内分析。
PLoS One. 2023 Aug 28;18(8):e0290297. doi: 10.1371/journal.pone.0290297. eCollection 2023.
4
Therapy of cutaneous leishmaniasis caused by Leishmania braziliensis with fluconazole.用氟康唑治疗巴西利什曼原虫引起的皮肤利什曼病。
Dermatol Ther. 2021 Sep;34(5):e15060. doi: 10.1111/dth.15060. Epub 2021 Jul 18.
5
Interventions for American cutaneous and mucocutaneous leishmaniasis.美国皮肤利什曼病和黏膜皮肤利什曼病的干预措施。
Cochrane Database Syst Rev. 2020 Aug 27;8(8):CD004834. doi: 10.1002/14651858.CD004834.pub3.
6
Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis.脂质体两性霉素B治疗巴西利什曼原虫引起的新大陆皮肤利什曼病失败
Intern Med. 2020;59(9):1227-1230. doi: 10.2169/internalmedicine.4096-19. Epub 2020 May 1.
7
Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform.利什曼原虫属对抗两性霉素 B 和氟康唑的敏感性检测,使用 Sensititre™ YeastOne™ YO9 平台。
BMC Infect Dis. 2019 Jul 8;19(1):593. doi: 10.1186/s12879-019-4237-3.
8
CYP51 as drug targets for fungi and protozoan parasites: past, present and future.细胞色素P450 51作为真菌和原生动物寄生虫的药物靶点:过去、现在与未来
Parasitology. 2018 Dec;145(14):1820-1836. doi: 10.1017/S0031182018000562. Epub 2018 Apr 12.
9
Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.氟康唑治疗巴西亚马逊地区圭亚那利什曼原虫引起的皮肤利什曼病失败:一项开放、非随机的 2 期试验。
PLoS Negl Trop Dis. 2018 Feb 26;12(2):e0006225. doi: 10.1371/journal.pntd.0006225. eCollection 2018 Feb.
10
Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.唑类疗法治疗皮肤利什曼病的疗效:一项系统评价和荟萃分析。
PLoS One. 2017 Oct 9;12(10):e0186117. doi: 10.1371/journal.pone.0186117. eCollection 2017.